Analysts have nudged their fair value estimate for GoodRx Holdings slightly lower, from about US$4.95 to roughly US$4.56 per share, while also modestly increasing the discount rate from around 9.79% ...

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other best telehealth ...

GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the best stocks under $3 to invest in, although one firm had recently become ...

For the third quarter, GoodRx booked revenue of just over $195.3 million, representing growth of 8% over the same period of 2023. Non-GAAP (adjusted) net income was $31.9 million, or $0.08 per share, ...

As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones and S&P 500 posting ...

There's another fight brewing around GLP-1 drugs -- this time on the delivery side.

Across the recent three months, 4 analysts have shared their insights on GoodRx Holdings (NASDAQ:GDRX), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

In February 2026, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to offer eligible U.S. consumers savings of up to 30% on ARAKODA, the only FDA-approved, once-weekly prescription ...

SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (GDRX) (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will ...

GoodRx Holdings (GDRX) has received a new Buy rating, initiated by Leerink Partners analyst, Jim Kelly. Jim Kelly has given his Buy rating due to a combination of factors related to GoodRx Holdings’ ...

Analysts' ratings for GoodRx Holdings (NASDAQ:GDRX) over the last quarter vary from bullish to bearish, as provided by 8 analysts. The table below offers a condensed view of their recent ratings, ...

GoodRx Holdings Inc GDRX reported better-than-expected second-quarter financial results. GoodRx Holdings reported quarterly sales of $189.7 million, down 1% Y/Y, beating the consensus of $186.82 ...